The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation
Main Authors: | N Fleeman, C McLeod, A Bagust, S Beale, A Boland, Y Dundar, A Jorgensen, K Payne, M Pirmohamed, S Pushpakom, T Walley, P de Warren-Penny, R Dickson |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2010-01-01
|
Series: | Health Technology Assessment |
Online Access: | https://doi.org/10.3310/hta14030 |
Similar Items
-
Rituximab for the first-line treatment of stage III/IV follicular non-Hodgkin's lymphoma
by: Y Dundar, et al.
Published: (2009-06-01) -
The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation
by: J Hockenhull, et al.
Published: (2008-04-01) -
Drug-eluting stents: a systematic review and economic evaluation
by: R Hill, et al.
Published: (2007-11-01) -
Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
by: J Greenhalgh, et al.
Published: (2009-10-01) -
Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation
by: C McLeod, et al.
Published: (2009-01-01)